SUPERVALU PHARMACIES INC
Community/Retail Pharmacy · STILLWATER, MN
Organization Active NPI 1184700049
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 14,852 | 53,470 | $3,990,622 | $3,872,179 | $3,872,179 |
| 2023 | 19,561 | 85,919 | $3,688,682 | $3,500,891 | $3,500,891 |
| 2022 | 26,780 | 104,133 | $2,920,200 | $2,783,215 | $2,783,215 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 90480 | Admn sarscov2 vacc 1 dose | 13,969 | $31 | $31 |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | 13,159 | $155 | $155 |
| G0008 | Administration of influenza virus vaccine | 12,416 | $17 | $17 |
| 90662 | Influenza vaccine split virus, preservative free | 11,415 | $82 | $82 |
| 90656 | Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 843 | $22 | $22 |
| 91320 | Sarscv2 vac 30mcg trs-suc im | 411 | $133 | $133 |
| 91304 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage, for intramuscular use | 400 | $158 | $158 |
| G0009 | Administration of pneumococcal vaccine | 346 | $18 | $18 |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 345 | $290 | $290 |
| 90673 | Influenza vaccine, trivalent derived from recombinant dna | 113 | $82 | $82 |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 43 | $22 | $22 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Community/Retail Pharmacy | 3336C0003X | ✓ | — | — |
Other Community/Retail Pharmacy providers in Minnesota
- NPI 1881788289
- NPI 1598870636
- NPI 1740635770
- NPI 1366765539
- NPI 1912796798
- NPI 1497159867
- NPI 1164102661
- NPI 1497377287
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.